Gupta, Revant
Universitätsklinikum Tübingen · University of Tübingen
3 papers on CoChatORCID 0000-0002-0881-5074
Most cited papers
- Verified
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature
Cancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and Prognosis
Cited by 1,294
- Verified
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
Kotsiliti, E., Leone, V., Schuehle, S., Govaere, O., Li, H., Wolf, M. J., Horvatic, H., Bierwirth, S., Hundertmark, J., Inverso, D., et al. (2023) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 108
- Verified
Deterministic scRNA-seq captures variation in intestinal crypt and organoid composition
Bues, J., Biočanin, M., Pezoldt, J., Dainese, R., Chrisnandy, A., Rezakhani, S., Saelens, W., Gardeux, V., Gupta, R., Sarkis, R., et al. (2022) · Nature Methods
Single-cell and spatial transcriptomicsInnovative Microfluidic and Catalytic Techniques Innovation
Cited by 71
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free